A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1329-30. doi: 10.1161/01.ATV.0000139012.45265.e0.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anticholesteremic Agents / therapeutic use*
  • Cholesterol, LDL / blood
  • Clinical Trials as Topic / statistics & numerical data*
  • Coronary Disease / epidemiology
  • Coronary Disease / prevention & control
  • Goals
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypercholesterolemia / drug therapy*
  • Hypercholesterolemia / epidemiology
  • Practice Guidelines as Topic*
  • Randomized Controlled Trials as Topic / statistics & numerical data
  • Risk
  • Triglycerides / blood

Substances

  • Anticholesteremic Agents
  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Triglycerides